Cargando…

A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study

Background and Objective: The study aims to investigate the correlation between Hepatitis B ‘e’ antigen (HBeAg) and HBV DNA levels, and to find a convenient tool to estimate the HBV DNA level for clinicians. Materials and Methods: We enrolled 1020 patients in this cross-sectional study and divided t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Zheng, Jinli, Huang, Yang, Pu, Xingyu, Jiang, Li, Yang, Jiayin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500857/
https://www.ncbi.nlm.nih.gov/pubmed/36143956
http://dx.doi.org/10.3390/medicina58091279
_version_ 1784795325684252672
author Wang, Ning
Zheng, Jinli
Huang, Yang
Pu, Xingyu
Jiang, Li
Yang, Jiayin
author_facet Wang, Ning
Zheng, Jinli
Huang, Yang
Pu, Xingyu
Jiang, Li
Yang, Jiayin
author_sort Wang, Ning
collection PubMed
description Background and Objective: The study aims to investigate the correlation between Hepatitis B ‘e’ antigen (HBeAg) and HBV DNA levels, and to find a convenient tool to estimate the HBV DNA level for clinicians. Materials and Methods: We enrolled 1020 patients in this cross-sectional study and divided them into four groups: an HbeAg-positive and -negative group, and high and low HBV DNA levels groups. Results: Alanine aminotransferase (ALT), Albumin (ALB) and HBeAg are independent risk factors for CHB patients. When the level of HBeAg is higher than 16.15 S/CO, it is four times more likely that the patients will have high levels of HBV DNA than those who do not. The ALT and TB are independent risk factors in HBeAg-negative patients with a high HBV DNA level. We have drawn three predictive models to estimate the HBV DNA levels for those with the chronic hepatitis B virus (CHB), and those that are HBeAg-positive and HBeAg-negative (Y(1) = 0.004 × ALT(IU/L) + 1.412 × HBeAg (S/CO) − 0.029 × ALB (g/L) + 0.779, the AUC is 0.672, and the cutoff value is −0.072, there the sensitivity is 0.615, the specificity is 0.648, PPV is 65.182% and NPV is 60.837%; Y(2) = 0.007 × HBeAg (S/CO) − 0.016 × HGB (g/L) + 3.070, the AUC is 0.724, and the cutoff value is 1.216, where the sensitivity is 0.626, the specificity is 0.897, PPV is 94.118% and NPV is 34.437%; Y(3) = −0.005 × ALT(IU/L) + 0.006 × TB (umol/L) + 0.385, the AUC is 0.661, and the cutoff value is 0.263, where the sensitivity is 0.677, the specificity is 0.587, PPV is 66.820% and NPV is 40.774%, respectively). We propose that HBeAg is the most important risk factor for the patient with a high HBV DNA level, however, it is not as important in the HBeAg-positive group. Conclusions: HBeAg is an independent risk factor that reflects the level of HBV DNA with a strong correlation. Patient with HBeAg (−) should combine TB and ALT to estimate the level of HBV DNA.
format Online
Article
Text
id pubmed-9500857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95008572022-09-24 A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study Wang, Ning Zheng, Jinli Huang, Yang Pu, Xingyu Jiang, Li Yang, Jiayin Medicina (Kaunas) Article Background and Objective: The study aims to investigate the correlation between Hepatitis B ‘e’ antigen (HBeAg) and HBV DNA levels, and to find a convenient tool to estimate the HBV DNA level for clinicians. Materials and Methods: We enrolled 1020 patients in this cross-sectional study and divided them into four groups: an HbeAg-positive and -negative group, and high and low HBV DNA levels groups. Results: Alanine aminotransferase (ALT), Albumin (ALB) and HBeAg are independent risk factors for CHB patients. When the level of HBeAg is higher than 16.15 S/CO, it is four times more likely that the patients will have high levels of HBV DNA than those who do not. The ALT and TB are independent risk factors in HBeAg-negative patients with a high HBV DNA level. We have drawn three predictive models to estimate the HBV DNA levels for those with the chronic hepatitis B virus (CHB), and those that are HBeAg-positive and HBeAg-negative (Y(1) = 0.004 × ALT(IU/L) + 1.412 × HBeAg (S/CO) − 0.029 × ALB (g/L) + 0.779, the AUC is 0.672, and the cutoff value is −0.072, there the sensitivity is 0.615, the specificity is 0.648, PPV is 65.182% and NPV is 60.837%; Y(2) = 0.007 × HBeAg (S/CO) − 0.016 × HGB (g/L) + 3.070, the AUC is 0.724, and the cutoff value is 1.216, where the sensitivity is 0.626, the specificity is 0.897, PPV is 94.118% and NPV is 34.437%; Y(3) = −0.005 × ALT(IU/L) + 0.006 × TB (umol/L) + 0.385, the AUC is 0.661, and the cutoff value is 0.263, where the sensitivity is 0.677, the specificity is 0.587, PPV is 66.820% and NPV is 40.774%, respectively). We propose that HBeAg is the most important risk factor for the patient with a high HBV DNA level, however, it is not as important in the HBeAg-positive group. Conclusions: HBeAg is an independent risk factor that reflects the level of HBV DNA with a strong correlation. Patient with HBeAg (−) should combine TB and ALT to estimate the level of HBV DNA. MDPI 2022-09-15 /pmc/articles/PMC9500857/ /pubmed/36143956 http://dx.doi.org/10.3390/medicina58091279 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Ning
Zheng, Jinli
Huang, Yang
Pu, Xingyu
Jiang, Li
Yang, Jiayin
A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title_full A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title_fullStr A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title_full_unstemmed A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title_short A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
title_sort predictive model to evaluate the hbeag positivity of chronic hepatitis b virus patients in clinics: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500857/
https://www.ncbi.nlm.nih.gov/pubmed/36143956
http://dx.doi.org/10.3390/medicina58091279
work_keys_str_mv AT wangning apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT zhengjinli apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT huangyang apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT puxingyu apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT jiangli apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT yangjiayin apredictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT wangning predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT zhengjinli predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT huangyang predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT puxingyu predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT jiangli predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy
AT yangjiayin predictivemodeltoevaluatethehbeagpositivityofchronichepatitisbviruspatientsinclinicsacrosssectionalstudy